a provider of biopharmaceutical development services and commercial outsourcing services
Industry MedicalSpecialties
A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.
Ticker / NAME | Correlation To IQV | 1D Price Change % | ||
---|---|---|---|---|
IQV | 100% | -0.96% | ||
CRL - IQV | 73% Closely correlated | -4.35% | ||
ICLR - IQV | 64% Loosely correlated | -3.94% | ||
MEDP - IQV | 52% Loosely correlated | +0.31% | ||
AZTA - IQV | 51% Loosely correlated | -3.22% | ||
MTD - IQV | 48% Loosely correlated | -0.18% | ||
More |
Ticker / NAME | Correlation To IQV | 1D Price Change % |
---|---|---|
IQV | 100% | -0.96% |
IQV (2 stocks) | 92% Closely correlated | -4.39% |
innovating biotech (18 stocks) | 62% Loosely correlated | -2.05% |
outsourcing (31 stocks) | 61% Loosely correlated | -2.94% |
Medical Specialties (418 stocks) | 50% Loosely correlated | -1.48% |
Medical Specialties (428 stocks) | 50% Loosely correlated | -1.28% |
More |